Prof. Sam Emaminejad has been awarded a PhRMA Fellowship in Translational Medicine and Therapeutics Program. The mission of the PhRMA Foundation is to support young scientists in disciplines important to the pharmaceutical industry by awarding them competitive research fellowships and grants at a critical decision point at the outset of their careers.

The goal of the PhRMA Foundation’s Translational Medicine and Therapeutics Program is to promote the development and use of experimental and computational methods in an integrative approach towards clinical needs in diagnosis, treatment and prevention. The Foundation emphasizes close collaborations with clinicians to identify critical unmet clinical needs.